Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study addresses postures and range of motion in cervical dystonia (Spasmodic Torticollis). It uses 3D miniature and wireless motion captures sensors, and aims to increase the understanding of the biomechanics of the movement disorders of the cervical column in this pathology. In addition, the clinical state of cervical dystonia of the patients will be assessed, using the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS). The investigators will compare the results between control and study groups.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Cervical dystonia | |||
| matched controlled subjects | matched in age (+/- 5 years) and gender |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Range of motion of the voluntary mobility of the cervical spine in the three spatial planes | Range of motion of the voluntary mobility of the cervical spine in the three spatial planes, measured in patients and matched control subjects | baseline |
| Measure | Description | Time Frame |
|---|---|---|
| movements disorders in cervical dystonia | correlations between the movements disorders (range of motion, angular velocity, direction deviation) and the clinical characteristics of cervical dystonia, among patients with cervical dystonia | baseline |
| head posture |
| Measure | Description | Time Frame |
|---|---|---|
| score on the Toronto Western Spasmodic torticolis rating scale | clinical characteristics of cervical dystonia | baseline |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Study-group: 30 patients meeting the criteria for cervical dystonia (Spasmodic Torticollis) and without botulinum toxin injections during the last 6 previous months before baseline. Patients will be selected consecutively among the outpatients with movement disorder of 3 study sites: Fondation OPH Rothschild, Salpetriere Hospital and Sainte-Anne Hospital (Paris)
Control-group: 30 healthy volunteers matched in age (+/- 5 years) and gender with the 30 CD subjects. They will be selected in Sainte-Anne Hospital (Paris)
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sangla Sophie, MD | Fondation Ophtalmologique Adolphe de Rothschild | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Fondation Ophtalmologique Adolphe de Rothschild | Paris | Île-de-France Region | 75019 | France |
Not provided
| ID | Term |
|---|---|
| D014103 | Torticollis |
| ID | Term |
|---|---|
| D004421 | Dystonia |
| D020820 | Dyskinesias |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
influence of vision on the head posture |
| baseline |
| range of motion | influence of vision on the range of motion | baseline |
| D013568 |
| Pathological Conditions, Signs and Symptoms |